凯立新材(688269) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 reached ¥420,299,397.58, representing a year-on-year increase of 27.08%[3] - The total profit for the period was ¥22,898,427.75, reflecting a growth of 24.68% compared to the same quarter last year[3] - The net profit attributable to shareholders was ¥21,893,965.08, which is an increase of 26.81% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥24,874,460.62, showing a significant increase of 60.82% compared to the same period last year[3] - The basic earnings per share for the quarter was ¥0.17, up by 30.77% from the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥1,434,739,631.86, a 25.5% increase from ¥1,143,179,877.40 in the same period of 2024[17] - Net profit for the first three quarters of 2025 was ¥82,962,114.32, representing a 29.6% increase compared to ¥63,993,284.11 in the previous year[18] - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.64, up from ¥0.49 in the same period of 2024[19] - The total comprehensive income for the period was 70,775,242.77 RMB, slightly down from 73,454,914.16 RMB in the previous year[27] - The company reported a total comprehensive income of ¥80,709,164.77 for the first three quarters of 2025, compared to ¥65,166,118.02 in the previous year[18] Research and Development - Research and development expenses totaled ¥16,586,824.39, marking a 43.46% increase compared to the same quarter last year[4] - Research and development expenses increased to ¥40,340,474.05, a rise of 19.8% from ¥33,682,861.67 in the same period of 2024[17] - Research and development expenses for the first three quarters of 2025 were CNY 38,059,798.39, up from CNY 33,682,861.67 in the same period last year, marking an increase of approximately 13%[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,100,713,628.45, a 2.41% increase from the end of the previous year[4] - As of September 30, 2025, total current assets amounted to ¥945,918,740.34, a decrease from ¥983,178,589.55 as of December 31, 2024, representing a decline of approximately 3.8%[13] - The company's cash and cash equivalents decreased significantly from ¥304,200,777.44 to ¥155,774,747.26, a drop of about 48.9%[13] - Accounts receivable increased from ¥155,833,042.87 to ¥237,536,427.93, reflecting a growth of approximately 52.3%[13] - Inventory rose from ¥332,660,956.80 to ¥366,563,102.04, indicating an increase of about 10.2%[13] - Total liabilities decreased slightly from ¥1,546,459,499.96 to ¥1,505,850,464.26, a reduction of approximately 2.6%[14] - The company's fixed assets increased from ¥695,699,937.24 to ¥826,591,556.92, showing a growth of about 18.8%[14] - Non-current assets totaled ¥1,154,794,888.11, up from ¥1,068,162,169.15, representing an increase of approximately 8.1%[14] - The total assets of the company reached ¥2,100,713,628.45, compared to ¥2,051,340,758.70, marking an increase of about 2.4%[14] - Total liabilities amounted to ¥1,029,696,755.52, an increase from ¥999,321,050.54 year-over-year[15] - The total liabilities decreased slightly to CNY 694,704,708.66 from CNY 699,161,213.15, representing a reduction of about 0.66%[23] Cash Flow - Cash flow from operating activities showed a net outflow of ¥82,074,845.54, compared to a net outflow of ¥31,892,407.79 in the previous year[20] - The net cash flow from operating activities for the first three quarters of 2025 was -72,752,740.01 RMB, compared to 68,707,148.48 RMB in the same period of 2024, indicating a significant decline[29] - Cash received from sales of goods and services increased to 1,009,481,737.03 RMB in the first three quarters of 2025, up from 768,094,545.38 RMB in 2024, representing a growth of approximately 31.4%[29] - The total cash outflow from operating activities was 1,232,393,651.73 RMB, compared to 956,008,537.35 RMB in the previous year, reflecting an increase of about 29%[29] - The cash flow from investing activities showed a net outflow of -18,420,592.10 RMB in 2025, an improvement from -243,629,803.17 RMB in 2024[29] - Cash inflow from financing activities was 406,659,680.00 RMB in 2025, compared to 337,000,000.00 RMB in 2024, marking an increase of approximately 20.6%[30] - The net cash flow from financing activities was -44,927,408.70 RMB in 2025, a decrease from 116,482,358.42 RMB in 2024, indicating a shift in financing strategy[30] - The ending cash and cash equivalents balance decreased to 95,984,590.14 RMB in 2025 from 179,495,388.42 RMB in 2024, a decline of about 46.6%[30] Sales Performance - The catalyst sales volume increased by 23.18% year-on-year, contributing to the overall revenue growth[7] - The company reported a significant increase in sales in the pharmaceutical and basic chemical sectors, with respective growth rates of 45.38% and 96.66%[7] Other Financial Metrics - The weighted average return on equity increased to 2.15%, up by 0.38 percentage points year-on-year[4] - Other comprehensive income after tax was a loss of ¥2,252,949.55, compared to a gain of ¥1,172,833.91 in the same period of 2024[18] - The company's total equity attributable to shareholders reached ¥1,028,969,406.09, up from ¥1,013,485,099.31 in the previous year[15] - The company reported a total equity of CNY 1,006,098,987.48 as of September 30, 2025, compared to CNY 1,000,675,744.71 at the end of 2024, reflecting a growth of approximately 0.54%[24] - The financial expenses for the first three quarters of 2025 were CNY 4,730,170.58, slightly higher than CNY 4,246,919.31 in the same period last year, indicating an increase of about 11%[26] Accounting Standards - The company has not adopted new accounting standards for the current reporting period, maintaining consistency in financial reporting[31]